Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Immunodeficiency (PID)”

83 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 83 results

Large-scale testing (Phase 3)Study completedNCT00168025
What this trial is testing

Efficacy and Safety of Intravenous Immunoglobulin IgPro10 in Patients With Primary Immunodeficiencies (PID)

Who this might be right for
AgammaglobulinemiaIgG DeficiencyCommon Variable Immunodeficiency
CSL Behring 89
Not applicableStudy completedNCT06150534
What this trial is testing

At-Home Subcutaneous Immunoglobulin Replacement Therapy Using Alexa Skill

Who this might be right for
Primary Immunodeficiency Diseases (PID)
Takeda 22
Large-scale testing (Phase 3)Study completedNCT00538915
What this trial is testing

Open Label, Phase III Study of NABI-IGIV 10% [Immune Globulin Intravenous(Human), 10%] In Subjects With Primary Immune Deficiency Disorders (PIDD)

Who this might be right for
Primary Immune Deficiency Disorders (PIDD)
ADMA Biologics, Inc. 63
Large-scale testing (Phase 3)Study completedNCT00168012
What this trial is testing

Efficacy and Safety of Intravenous Immunoglobulin IVIG-F10 in Patients With Primary Immunodeficiencies (PID)

Who this might be right for
AgammaglobulinemiaIgG DeficiencyCommon Variable Immunodeficiency
CSL Behring 42
Large-scale testing (Phase 3)Study completedNCT02327351
What this trial is testing

TCR Alpha/Beta Depletion for HSCT From Haploidentical and Unrelated Donors in the Treatment of PID

Who this might be right for
Primary Immune Deficiency DisorderHematopoietic Stem Cell Transplantation
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 98
Large-scale testing (Phase 3)Study completedNCT01814800
What this trial is testing

Pharmacokinetics, Efficacy, and Safety Study of RI-002 (IGIV) in Subjects With Primary Immunodeficiency Diseases (PIDD)

Who this might be right for
Primary Immune Deficiency Disorder
ADMA Biologics, Inc. 59
Not applicableStudy completedNCT02593188
What this trial is testing

Non-Interventional Post-Marketing Safety Study on the Long-Term Safety of HYQVIA (Global)

Who this might be right for
Primary Immunodeficiency Diseases (PID)
Baxalta now part of Shire 264
Large-scale testing (Phase 3)Study completedNCT01461018
What this trial is testing

Multicenter Study of Long-Term Clinical Outcomes of Subcutaneous Immune Globulin IgPro20 in Subjects With Primary Immunodeficiency (Japan Study)

Who this might be right for
Primary Immune Deficiency
CSL Behring 22
Large-scale testing (Phase 3)Study completedNCT00814320
What this trial is testing

Gammagard Liquid and rHuPH20 in PID

Who this might be right for
Primary Immunodeficiency Diseases (PID)
Baxalta now part of Shire 89
Not applicableStudy completedNCT01859754
What this trial is testing

Octagam 5% Versus Comparator Post Marketing Trial

Who this might be right for
Primary Immune Deficiency Disorder
Octapharma 623
Not applicableLooking for participantsNCT04528355
What this trial is testing

Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC

Who this might be right for
Primary Immunodeficiency (PID)Congenital Bone Marrow Failure SyndromesInherited Metabolic Disorders (IMD)+2 more
Paul Szabolcs 50
Post-approval studies (Phase 4)Study completedNCT02180763
What this trial is testing

Gammanorm Quality of Life Study in Immunodeficient Patients Using Rapid Push or Pumps

Who this might be right for
Primary Immunodeficiency (PID)
Octapharma 31
Large-scale testing (Phase 3)Study completedNCT03961009
What this trial is testing

Clinical Assessment of Pharmacokinetics, Efficacy, and Safety of 10% IVIg in PID Patients

Who this might be right for
Primary Immunodeficiency Disease
Kedrion S.p.A. 47
Not applicableUnknownNCT01617122
What this trial is testing

Evaluate Bacteriophage as a Useful Immunogen in Patients With Primary Immune Deficiency Diseases (PIDD)

Who this might be right for
Primary Immune Deficiency Diseases
University of South Florida 200
Large-scale testing (Phase 3)Study completedNCT05513586
What this trial is testing

Evaluate the Long-term Safety of TAK-771 in Japanese Primary Immunodeficiency Disease (PID) Participants

Who this might be right for
Primary Immunodeficiency Diseases (PID)
Takeda 15
Large-scale testing (Phase 3)UnknownNCT06089122
What this trial is testing

Efficacy, Safety, and Pharmacokinetics of Shu Yang IVIG

Who this might be right for
Primary Immunodeficiency Disease
Azidus Brasil 50
Post-approval studies (Phase 4)Study completedNCT01289847
What this trial is testing

Find Out How Safe and Effective Gammaplex® is in Young People With Primary Immunodeficiency

Who this might be right for
Primary Immune Deficiency DisordersCommon Variable ImmunodeficiencyX-linked Agammaglobulinemia+2 more
Bio Products Laboratory 25
Large-scale testing (Phase 3)Study completedNCT05150340
What this trial is testing

TAK-771 in Japanese People With Primary Immunodeficiency Diseases (PID)

Who this might be right for
Primary Immunodeficiency Diseases (PID)
Takeda 16
Post-approval studies (Phase 4)Looking for participantsNCT07076446
What this trial is testing

An Open-label, Multicenter Study to Assess the Pharmacokinetics (PK), Safety, and Tolerability of Subcutaneous IgPro20 in Immunoglobulin (IG) Treatment-naïve Participants With Primary Immunodeficiency (PID)

Who this might be right for
Primary Immunodeficiency
CSL Behring 8
Large-scale testing (Phase 3)Looking for participantsNCT06076642
What this trial is testing

A Study About the Long-Term Safety of TAK-881 in People With Primary Immunodeficiency Diseases

Who this might be right for
Primary Immunodeficiency Diseases (PID)
Takeda 39
Load More Results